2-carboxymethyl-5-dimethylamino-benzoic acid | 67755-31-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-carboxymethyl-5-dimethylamino-benzoic acid
• 英文别名: (2-carboxy-4-dimethylamino-phenyl)-acetic acid；(2-Carboxy-4-dimethylamino-phenyl)-essigsaeure；2-Carboxymethyl-5-dimethylamino-benzoesaeure；2-(Carboxymethyl)-5-(dimethylamino)benzoic acid
• CAS: 67755-31-1
• 化学式: C₁₁H₁₃NO₄
• 分子量: 223.229
• InChiKey: CZNSRXYJKFYKFV-UHFFFAOYSA-N

物化性质

• 沸点：
  452.9±35.0 °C(Predicted)
• 密度：
  1.333±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  77.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-carboxymethyl-5-dimethylamino-benzoic acid 在 邻二氯苯 作用下， 生成 7-dimethylamino-2-hydroxy-4H-isoquinoline-1,3-dione
  参考文献：
  名称：

  N-羟基酰亚胺。第二部分 同苯二甲酸和邻苯二甲酸的衍生物

  摘要：

  DOI：

  10.1039/jr9550003518
• 作为产物：
  描述：

  2-乙酸基-4-硝基苯甲酸 在 甲醇 、 Pd/SrCO₃ 、 聚合甲醛 作用下， 生成 2-carboxymethyl-5-dimethylamino-benzoic acid
  参考文献：
  名称：

  N-羟基酰亚胺。第二部分 同苯二甲酸和邻苯二甲酸的衍生物

  摘要：

  DOI：

  10.1039/jr9550003518

文献信息

• Nitrogen-containing heterocyclic compounds
  申请人：Yamanouchi Pharmaceutical Co., Ltd.

  公开号：US04163844A1

  公开（公告）日：1979-08-07

  Novel nitrogen-containing heterocyclic compounds shown by the formula ##STR1## wherein Y represents an oxygen atom, a sulfur atom, or a group shown by ##STR2## (wherein m is 1 or 2); n represents 0 or 1; R.sub.1 and R.sub.4, which may be the same or different, each represents a hydrogen atom, a lower alkyl group, or a lower alkenyl group; R.sub.2 and R.sub.3, which may be the same or different, each represents a hydrogen atom, a hydroxyl group, a lower alkanoyloxy group, a lower alkyl group or a lower alkenyl group; said R.sub.2 and R.sub.3 may further form together a double bond; R.sub.5 and R.sub.6, which may be the same or different, each represents a hydrogen atom, a halogen atom, a hydroxyl group, a nitro group, an amino group, a lower alkoxy group, a mono or di lower alkylamino group, or a lower alkyl group; said R.sub.5 and R.sub.6 may further form together a lower alkylenedioxy group; and R.sub.7 represents a hydrogen atom, a halogen atom, a lower alkanoyl group, a phenyl group, a phenyl lower alkyl group, a lower alkyl group, a hydroxy lower alkyl group, a di lower alkylamino lower alkyl group, a pyrrolidino lower alkyl group, a piperidino lower alkyl group, a morpholino lower alkyl group, or a 4-lower alkylpiperazino lower alkyl group; (1) when said R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are hydrogen atom and n is 0, said Y is a group shown by ##STR3## and (2) when said R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.7 are hydrogen atom, at least one of said R.sub.5 and R.sub.6 is the aforesaid group other than hydrogen atom, and n is 0, said Y is oxygen atom or a group shown by ##STR4## and the pharmacologically acceptable non-toxic salts thereof. The compounds are strong analgesic anti-inflammatory agents.

  根据以下公式显示的新型含氮杂环化合物：其中Y代表氧原子、硫原子或由##STR2##所示的基团（其中m为1或2）；n代表0或1；R.sub.1和R.sub.4，可以相同也可以不同，分别代表氢原子、低烷基基团或低烯基基团；R.sub.2和R.sub.3，可以相同也可以不同，分别代表氢原子、羟基基团、低烷酰氧基团、低烷基基团或低烯基基团；所述的R.sub.2和R.sub.3还可以一起形成双键；R.sub.5和R.sub.6，可以相同也可以不同，分别代表氢原子、卤素原子、羟基基团、硝基基团、氨基基团、低烷氧基团、单或双低烷基氨基基团或低烷基基团；所述的R.sub.5和R.sub.6还可以一起形成低烷基二氧基基团；R.sub.7代表氢原子、卤素原子、低烷酰基团、苯基团、苯基低烷基基团、低烷基基团、羟基低烷基基团、双低烷基氨基低烷基基团、吡咯啉基低烷基基团、哌啶基低烷基基团、吗啉基低烷基基团或4-低烷基哌嗪基低烷基基团；（1）当所述的R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7为氢原子且n为0时，所述的Y是由##STR3##所示的基团；（2）当所述的R.sub.1、R.sub.2、R.sub.3、R.sub.4和R.sub.7为氢原子，至少其中一个所述的R.sub.5和R.sub.6是上述的非氢原子基团，且n为0时，所述的Y是氧原子或由##STR4##所示的基团，以及其药理学上可接受的无毒盐。这些化合物是强效止痛抗炎剂。
• Studies on the synthesis of condensed heterocyclic isoquinolone derivatives. I. Studies on the synthesis and pharmacology of thiazino, oxazino and pyrimido isoquinolones.
  作者：KAZUO KUBO、NORIKI ITO、YASUO ISOMURA、ISAO SOZU、HIROSHIGE HOMMA、MASUO MURAKAMI

  DOI：10.1248/cpb.27.2372

  日期：——

  5-Oxo-1, 2, 3, 5-tetrahydro-5H-imidazo [1, 2-b] isoquinoline (IIa) and related compounds were synthesized from homophthalic acid and an aliphatic 1, 2- or 1, 3-diamine. In addition, homophthalic acids or o-carboxyphenylmalonic acid diesters were allowed to react with an aliphatic 1, 2- or 1, 3-aminoalcohol or aminothiol with heating in the presence of p-toluenesulfonic acid, yielding a series of oxazolo- or oxazino-isoquinolones (VI) or thiazolo- or thiazino-isoquinolones (IV). Oxidation of IV gave the corresponding sulfoxides (VII) and sulfones (VIII). Treatment of o-cyanomethylbenzenesulfonyl chloride with an N-alkyl 1, 2- or 1, 3-diamine gave N-alkyl-imidazo- or pyrimido-benzothiazine-5, 5-dioxide (XI). The compounds thus prepared were evaluated for their anti-inflammatory effect in rats, using the carrageenin paw edema method, and some of the condensed heterocyclic isoquinolone derivatives were found to exhibit strong anti-inflammatory activity. These compounds were also examined for analgesic activity in terms of the inhibition of acetic acid induced writhing. Compound VIIIk showed stronger anti-inflammatory activity than phenylbutazone, as well as analgesic activity comparable to that of aminopyrine, and had very low toxicity.

  5-氧代-1，2，3，5-四氢-5H-咪唑并[1，2-b]异喹啉（IIa）及相关化合物由均苯二甲酸和脂肪族 1，2-或 1，3-二胺合成。此外，均苯二甲酸或邻羧基苯丙二酸二酯与脂肪族 1、2- 或 1、3-氨基醇或氨基硫醇在对甲苯磺酸存在下加热反应，可生成一系列噁唑或噁唑-异喹啉酮（VI）或噻唑或噻嗪-异喹啉酮（IV）。IV 氧化后得到相应的硫醚（VII）和砜（VIII）。用 N-烷基 1，2-或 1，3-二胺处理邻氰甲基苯磺酰氯，可得到 N-烷基咪唑或嘧啶基苯并噻嗪-5，5-二氧化物（XI）。采用角叉菜胶爪水肿法对由此制备的化合物进行了大鼠抗炎效果评估，发现其中一些缩合杂环异喹啉酮衍生物具有很强的抗炎活性。这些化合物还通过抑制醋酸引起的蠕动来检测其镇痛活性。化合物 VIIIk 显示出比苯基丁氮酮更强的抗炎活性，以及与氨基比林相当的镇痛活性，而且毒性很低。
• Antihistaminic aromatic tetrahydroazepinones (and thiones)
  申请人：A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation)

  公开号：EP0299663A2

  公开（公告）日：1989-01-18

  Aromatic tetrahydroazepinones and thiones having the formula: wherein Q is carbon or nitrogen; B is oxygen or sulfur; R is loweralkyl, cycloalkyl or phenylloweralkyl; Z is an amino or a heterocyclic amino containing radical; and Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, phenyl or trifluorophenyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.

  具有以下式子的芳香族四氢氮杂卓酮和硫酮 其中 Q 是碳或氮 B是氧或硫 R是低级烷基、环烷基或苯基低级烷基 Z 是氨基或含杂环氨基的基；以及 Y 是卤代、低级烷基、低级烷氧基、稀低级烷基氨基、硝基、苯基或三氟苯基； 本发明公开了具有抗组胺效用及其制备方法和化学中间体。
• KUBO, KAZUO;ITO, NORIKI;SOUZU, ISAO;ISOMURA, YASUO;HOMMA, HIROSHIGE
  作者：KUBO, KAZUO、ITO, NORIKI、SOUZU, ISAO、ISOMURA, YASUO、HOMMA, HIROSHIGE

  DOI：——

  日期：——
• US4163844A
  申请人：——

  公开号：US4163844A

  公开（公告）日：1979-08-07